Akari Therapeutics Plc (AKTX) stock
AKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.70−0.81 (-12.44%)
Close on Nov 17, 2026Market cap $11.10MP/E –Yield –
Akari Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Akari Therapeutics's total assets was $38.62M at Jun 30, 2026. For fiscal 2025 it was $47.89M, down 5.3% from the year before. Over ten years it grew -3.7% a year on average. The highest annual figure on record is $69.89M in fiscal 2015.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $47.89M | -5.3% |
| FY2024 | Dec 31, 2024 | $50.56M | +1061.0% |
| FY2023 | Dec 31, 2023 | $4.36M | -68.5% |
| FY2022 | Dec 31, 2022 | $13.83M | +18.7% |
| FY2021 | Dec 31, 2021 | $11.65M | -20.2% |
| FY2020 | Dec 31, 2020 | $14.60M | +125.4% |
| FY2019 | Dec 31, 2019 | $6.48M | -19.3% |
| FY2018 | Dec 31, 2018 | $8.03M | -72.4% |
| FY2017 | Dec 31, 2017 | $29.05M | -36.7% |
| FY2016 | Dec 31, 2016 | $45.87M | -34.4% |
| FY2015 | Dec 31, 2015 | $69.89M | +1958.9% |
| FY2014 | Dec 31, 2014 | $3.39M | -56.7% |
| FY2013 | Dec 31, 2013 | $7.83M | +599.3% |
| FY2012 | Dec 31, 2012 | $1.12M | +4048.1% |
| FY2011 | Dec 31, 2011 | $27.00K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $38.62M | -24.1% |
| Q1 FY2026 | Mar 31, 2026 | $33.89M | -33.5% |
| Q4 FY2025 | Dec 31, 2025 | $47.89M | -5.3% |
| Q3 FY2025 | Sep 30, 2025 | $45.38M | +1559.7% |
| Q2 FY2025 | Jun 30, 2025 | $50.91M | +903.0% |
| Q1 FY2025 | Mar 31, 2025 | $50.96M | +1738.3% |
| Q4 FY2024 | Dec 31, 2024 | $50.56M | +1061.0% |
| Q3 FY2024 | Sep 30, 2024 | $2.73M | -65.9% |
| Q2 FY2024 | Jun 30, 2024 | $5.08M | -63.3% |
| Q1 FY2024 | Mar 31, 2024 | $2.77M | -75.6% |
| Q4 FY2023 | Dec 31, 2023 | $4.36M | -62.6% |
| Q2 FY2023 | Jun 30, 2023 | $8.01M | +65.9% |
| Q4 FY2022 | Dec 31, 2022 | $13.83M | -5.3% |
| Q2 FY2022 | Jun 30, 2022 | $11.37M | -17.0% |
| Q4 FY2021 | Dec 31, 2021 | $11.65M | -19.4% |
| Q2 FY2021 | Jun 30, 2021 | $4.83M | -50.1% |
| Q4 FY2020 | Dec 31, 2020 | $14.60M | +125.4% |
| Q3 FY2020 | Sep 30, 2020 | $13.69M | +33.4% |
| Q2 FY2020 | Jun 30, 2020 | $14.45M | +213.3% |
| Q1 FY2020 | Mar 31, 2020 | $9.68M | +17.6% |
| Q4 FY2019 | Dec 31, 2019 | $6.48M | -19.3% |
| Q3 FY2019 | Sep 30, 2019 | $10.27M | -40.0% |
| Q2 FY2019 | Jun 30, 2019 | $4.61M | -84.1% |
| Q1 FY2019 | Mar 31, 2019 | $8.23M | -74.3% |
| Q4 FY2018 | Dec 31, 2018 | $8.03M | -82.5% |
| Q2 FY2018 | Jun 30, 2018 | $17.12M | -70.3% |
| Q4 FY2017 | Dec 31, 2017 | $29.05M | -53.9% |
| Q2 FY2017 | Jun 30, 2017 | $32.05M | -54.1% |
| Q4 FY2016 | Dec 31, 2016 | $45.87M | -42.1% |
| Q2 FY2016 | Jun 30, 2016 | $57.63M | +1847.1% |
| Q1 FY2016 | Mar 31, 2016 | $62.96M | +1358.4% |
| Q4 FY2015 | Dec 31, 2015 | $69.89M | +1958.9% |
| Q3 FY2015 | Sep 30, 2015 | $79.17M | – |
| Q2 FY2015 | Jun 30, 2015 | $2.96M | – |
| Q1 FY2015 | Mar 31, 2015 | $4.32M | – |
| Q4 FY2014 | Dec 31, 2014 | $3.39M | – |
See a number that looks wrong?